CTI has managed all phases of drug development from regulatory pathway design to market and indication expansion strategy. We assist sponsors in their drug development efforts through an integrated approach that includes clinical, scientific, and marketing expertise.
CTI has the global infrastructure, site relationships, and health outcomes expertise to execute Phase IV, Registry, and Expanded Access Programs effectively.Learn More
Our expertise allows us to develop educational program strategies and to identify the best format to meet our sponsor's needs.Learn More
Our team of experts frequently conduct literature reviews which provide the basis for drug development planning, clinical study design and have become a significant element of regulatory submissions, especially in rare diseases.Learn More